Clinical trial Recruiting at 1 site Observational Ages 18 and up

ML-based diagnosis of blocked arteries in patients with a left bundle branch block

Official title: Development of a Machine Learning Model for the Diagnosis of Occlusive Myocardial Infarction in the Setting of Left Bundle Branch Block

Run by Konya City Hospital · NCT07620119 · Data updated 2026-11-12

Doctors are testing a machine learning tool that uses digital ECGs to see if a blocked coronary artery is present in patients with a left bundle branch block.

More Myocardial Infarction trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorKonya City Hospital
Academic / other
Locations1 site (Konya, Karatay)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2026
Study endsJanuary 31, 2027
Registry record updatedJune 2, 2026
Trial IDNCT07620119 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with chest pain or ischemia-like symptoms and a confirmed or new/chronic LBBB who undergo invasive coronary angiography during the same admission.

Probably not a fit

Patients without LBBB or those who do not undergo angiography during the index admission may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects digital 12-lead ECG data from adults with chest pain and known or suspected left bundle branch block who undergo invasive coronary angiography. A machine learning model will be developed and tested to predict true coronary occlusion from raw ECG waveforms. The research aims to determine whether AI can improve rapid identification of acute myocardial infarction in this challenging subgroup. Enrollment requires consent and an index hospital admission with angiography performed. The study analyzes ECG signals and invasive imaging to correlate ML predictions with angiographic findings.

Why it matters

Potential benefit: If successful, the model could help emergency clinicians quickly identify patients who need urgent care despite LBBB, potentially speeding treatment decisions.

How similar studies have gone: AI analysis of ECG signals for AMI detection has shown promise in prior work, but this specific LBBB-focused approach is relatively novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years and older who present to the emergency department. Patients presenting with acute ischemic chest pain or clinical ischemia-equivalent symptoms (such as acute dyspnea, unexplained diaphoresis, or syncope).

Patients with a confirmed Left Bundle Branch Block (LBBB) on their initial 12-lead electrocardiogram (ECG), which can be either newly developed or known/chronic.

Patients who undergo invasive coronary angiography during their index hospital admission.

Patients or their legally authorized representatives who provide written informed consent to participate in the study.

Exclusion Criteria:

* Patients under the age of 18. Pregnant or lactating women. Patients with poor-quality or uninterpretable digital ECG recordings due to severe artifact, missing leads, or technical errors.

Patients who develop cardiopulmonary arrest before an initial diagnostic 12-lead ECG can be obtained in the emergency department.

Patients transferred from another healthcare facility who have already undergone coronary angiography or revascularization.

Patients who decline to participate or refuse to provide written informed consent.

Where it's running

  • Konya City Hospital
    Konya, Karatay, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.